昭衍新药：董事会审议通过《关于公司2025年年度报告全文及摘要的议案》等多项议案

Core Viewpoint - Zhaoyan New Drug announced the approval of multiple proposals, including the full text and summary of the 2025 annual report, during the second meeting of the fifth board of directors [1] Group 1 - The company held its second meeting of the fifth board of directors on March 30 [1] - The board approved the proposal regarding the 2025 annual report [1]